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Background: The difference between expert level (L3) reader and artificial intelligence (AI) performance for
quantifying coronary plaque and plaque components is unknown.
Objective: This study evaluates the interobserver variability among expert readers for quantifying the volume of
coronary plaque and plaque components on coronary computed tomographic angiography (CCTA) using an
artificial intelligence enabled quantitative CCTA analysis software as a reference (AI-QCT).
Methods: This study uses CCTA imaging obtained from 232 patients enrolled in the CLARIFY (CT EvaLuation by
ARtificial Intelligence For Atherosclerosis, Stenosis and Vascular MorphologY) study. Readers quantified overall
plaque volume and the % breakdown of noncalcified plaque (NCP) and calcified plaque (CP) on a per vessel
basis. Readers categorized high risk plaque (HRP) based on the presence of low-attenuation-noncalcified plaque
(LA-NCP) and positive remodeling (PR; ≥1.10). All CCTAs were analyzed by an FDA-cleared software service
that performs AI-driven plaque characterization and quantification (AI-QCT) for comparison to L3 readers.
Reader generated analyses were compared among readers and to AI-QCT generated analyses.
Results: When evaluating plaque volume on a per vessel basis, expert readers achieved moderate to high inter
observer consistency with an intra-class correlation coefficient of 0.78 for a single reader score and 0.91 for mean
scores. There was a moderate trend between readers 1, 2, and 3 and AI with spearman coefficients of 0.70, 0.68
and 0.74, respectively. There was high discordance between readers and AI plaque component analyses. When
quantifying %NCP v. %CP, readers 1, 2, and 3 achieved a weighted kappa coefficient of 0.23, 0.34 and 0.24,
respectively, compared to AI with a spearman coefficient of 0.38, 0.51, and 0.60, respectively. The intra-class
correlation coefficient among readers for plaque composition assessment was 0.68. With respect to HRP,
readers 1, 2, and 3 achieved a weighted kappa coefficient of 0.22, 0.26, and 0.17, respectively, and a spearman
coefficient of 0.36, 0.35, and 0.44, respectively.

Abbreviations: QCT, Quantitative Coronary Computed Tomographic Angiography; CCTA, Coronary computed tomography angiography; LA-NCP, Low Attenuation
Non-Calcified Plaque; HRP, High Risk Plaque; FDA, Food and Drug Administration; AI, Artificial Intelligence; CAD, Coronary Artery Disease; MDCT, Multidetector
Computed Tomography; LM, Left Main; LAD, Left Anterior Descending; LCx, Left Circumflex; RCA, Right Coronary Artery; CP, Calcified Plaque; NCP, Noncalcified
Plaque; QCA, quantitative coronary angiography; L3, Level 3; PV, plaque volume; PAV, percent atheroma volume; APCs, atherosclerotic plaque characteristics; HU,
Hounsfield units.
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Conclusion: Expert readers performed moderately well quantifying total plaque volumes with high consistency.
However, there was both significant interobserver variability and high discordance with AI-QCT when quanti
fying plaque composition.

1. Background

exclusions is provided in Fig. A1 of Appendix A.

Coronary computed tomography angiography (CCTA) is currently
indicated for imaging symptomatic patients at low to intermediate risk
for coronary artery disease (CAD) due to its ability to accurately rule out
severe stenosis.1 However, CCTA has a wider scope of capabilities
including quantifying plaque volume and plaque characteristics, which
can subsequently help clinicians identify CAD plaque burden, prognos
ticate disease progression, and risk stratify patients for future cardio
vascular events.2–4 Specifically, as the prognostic nature of plaque
burden and high-risk plaque characteristics (HRP), is substantiated in
the literature, it underscores the need to assess our capability for accu
rately and consistently assessing these markers.5–7
Most of the work published on interobserver variability within CCTA
analysis focuses on identifying and quantifying degrees of plaque sten
osis.8–11 However, the application of artificial intelligence enabled
quantitative CCTA evaluation (AI-QCT) has advanced our ability to
make plaque quantification and characterization assessments both
accurately and quickly compared to human readers.12 The diagnostic
benefit of quantifying high-risk plaque components and the quickly
expanding capabilities of applied AI makes the baseline interobserver
variability for quantifying plaque components, and how that perfor
mance compares to AI, relevant questions that are unanswered by the
current literature. This is the first study to assess expert interobserver
performance for categorizing both plaque burden and plaque composi
tion against a validated AI reference.

2.3. Artificial intelligence segmentation, plaque characterization and
quantification
CCTA studies were uploaded to and analyzed by an FDA-cleared
software in a blinded manner providing statistical services as deter
mined and requested by the study investigators.15,16 This is an AI-aided
approach that performs automated analysis of CCTA using a series of
validated convolutional neural network models (including VGG 19
network, 3D U-Net and VGG Network Variant) for image quality
assessment, coronary segmentation and labeling, lumen wall evaluation
and vessel contour determination and plaque characterization.17,18 A
full graphical representation of the algorithm is presented in Appendix
B. No manual interaction is required from the reader.
First, the AI-aided approach leverages 2 deep convolutional neural
networks, one to produce a centerline along the length of the vessel, and
another for lumen and outer vessel wall contouring. This approach is
applied to multiple phases of the CCTA examination, if present, and
enables phase-specific evaluation at the coronary segment vessel. The
algorithm reviews all series and determines the top 2 optimal series for
further analysis including vessel and lumen segmentation, plaque and
stenosis quantification. The algorithm rank-orders all available phases
for the segmentation of arteries. It then uses the top two phases inter
actively on a per vessel basis, e.g., the right coronary artery (RCA) will
be reconstructed from the phase which yields the highest RCA image
quality, while the posterior descending artery (PDA) may come from the
second phase if the PDA has a higher image quality on that phase. Once
coronary artery segmentation is performed, an automated labeling is
done to classify arteries by their location in the coronary tree as well as
within the proximal, mid or distal portions in a single vessel. The AI
further allows for defining of coronary artery lesions (i.e., those areas
where plaque is present). Utilizing a normal proximal reference vessel
cross-sectional slide and the cross-sectional slice that demonstrates the
greatest absolute narrowing, the software determines the start and end
of lesions and drops markers between which it calculates % diameter
stenosis and quantifies plaque burden. Within the lesions, plaque is
further characterized as low-attenuation non-calcified plaque, noncalcified plaque and calcified plaque based upon Hounsfield unit (HU)
densities of <30, 31 to 350, >350, respectively. Positive arterial
remodeling was identified as a remodeling index ≥1.10 by diameter
when compared to a normal proximal vessel reference.
We used a coronary artery territory-based analysis which included
the left main (LM), left anterior descending (LAD) including diagonals
and ramus intermedius, left circumflex (LCx) including obtuse marginals
and left-posterior descending and posterolateral branches, and RCA
including right posterolateral and PDA. For each territory we recorded
vessel length, vessel volume, lumen volume, total plaque volume,
calcified plaque volume, noncalcified plaque volume, low density non
calcified plaque volume, maximum diameter and area stenosis, and
maximum remodeling index. After the AI algorithm finishes all opera
tions, as mandated by the FDA, a quality control cardiac CT trained
technician reviews the results of the AI analysis in all cases with manual
adjustment if necessary. The QA process included visual inspection of
the lumen and vessel boundaries on the straightened multiplanar
reformat views of all vessels 1.5 mm and larger, as well as every crosssection of each of these vessels, placed at contiguous 0.25 mm in
crements. The time from data upload until AI completed processing was
recorded as well as any additional time required for technician or
physician quality assurance review.

2. Methods
2.1. Study enrollment and design
This is a retrospective study evaluating the imaging data of 232
patients enrolled in the CLARIFY (CT EvaLuation by ARtificial Intelli
gence For Atherosclerosis, Stenosis and Vascular MorphologY) tri
als,12,13 which identified consecutive patients undergoing CCTA for
acute and stable chest pain at high volume centers for cardiac CT. Pa
rameters including age, gender, body mass index (BMI), hypertension,
hyperlipidemia, diabetes, smoking history, family history of coronary
artery disease (CAD), statin use, antiplatelet therapy, and use of betablockers were all collected on enrollment and subsequently deidentified. The CLARIFY 1 and CLARIFY 2 trials used the data from
this cohort to test the performance of AI-QCT against various gold
standards for plaque assessment including L3 readers, quantitative
coronary angiography (QCA) and fractional flow reserve (FFR), focusing
on stenosis grading and plaque quantification.12,13 This study assesses
the interobserver variability of L3 readers for characterizing plaque and
identifying HRP using AI-QCT as a reference.
2.2. CCTA scan acquisition
CCTA scans were performed on a 64-MDCT General Electric VCT
(General Electric Healthcare, Milwaukee, Wisconsin; CVMG), and a 128DSCT Siemens FLASH (Siemens Healthcare, Erlangen, Germany; GWU
and Hospital de Santa Marta). Acquisition techniques included pro
spective and retrospective gating based upon institutional protocols.
Iterative reconstruction was used on the DSCT scanners but not on the
CVMG VCT. Patients received beta blockade, nitroglycerin and iodin
ated contrast in accordance with institutional and Society of Cardio
vascular Computed Tomography guidelines.14 Exams were
reconstructed in 5–10% increments. A diagram outlining CCTA
20
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Fig. 1. Box plots comparing level 3 reader versus AI derived plaque volume measurements
On a per vessel basis, there were moderately strong trends demonstrated between AI and readers. Intra-quintile distribution increased as plaque volumes increased.
Spearman coefficients were 0.70262, 0.68224, and 0.73835 for reader 1, 2, and 3, respectively compared to AI.

Fig. 2. 5 × 5 Contingency table of AI versus reader categorization of NCP and CP percentages by vessel
On a per vessel basis, there were poor trends demonstrated between AI and readers. Spearman coefficients were 0.37660, 0.50706 and 0.60281 for reader 1, 2, and 3,
respectively, with kappa coefficient showing poor agreement at 0.232, 0.337, and 0.239, respectively. Overall, readers tended to overestimate % CP.

2.4. Level 3 expert reads

2.6. Statistical analysis

Three advanced imaging attending physicians who were L3 readers,
ranging from 7 to 17 years of experience, performed blinded assessment
of CCTA. Each reader read each case independently and in distinct
reading sessions. The readers interpreted the original dataset and chose
phases independent of the AI image segmentation to calculate plaque
volume using a semi-quantitative software. They subsequently catego
rized plaque volume and its characteristics including %CP, %NCP, and
HRP on a territory basis.

The variability among L3 readers was evaluated using the intra-class
correlation coefficient. Correlation between L3 readers and AI was
evaluated using Spearman's correlation coefficient while agreement
between L3 readers and AI was evaluated with weighted kappa statistic.
Readers determined presence of two high risk plaque features—low
attenuation plaque <30 HU and positive arterial remodeling with a
remodeling index ≥1.10 by diameter on a per vessel territory basis. This
analysis was then compared with AI. This binary outcome was compared
by calculating the percent agreement and kappa statistic.

2.5. Atherosclerotic plaque volume and characterization

3. Results

Readers categorized plaque volume into one of five quintiles on a per
vessel basis. Similarly, plaque components including %NCP vs. %CP
were evaluated on a vessel territory basis and assigned to quintiles 1–5
with 1 signifying a vessel with >90% NCP, 2: %NCP 60–90%, 3: %NCP
40–60%, 4: %NCP 10–40% and 5: %NCP <10%. Readers also recorded
presence or absence of high-risk plaque features including positive
remodeling (PR) and low attenuation non-calcified plaque (LA-NCP).
Readers were provided multiple correlative examples of plaque cate
gories that corresponded to the quantified plaque quintiles described.
One example is provided in Fig. 3. A full evaluation of atherosclerotic
plaque volume and composition is provided in Table A1 of Appendix A.

3.1. Demographics and analysis time
The study population consisted of n = 232 patients who were mean
age 60 ± 12 years and 37% female. Among the study cohort, 61% had
hypertension, 69% had hyperlipidemia, 29% had diabetes and 38%
were smokers. The AI analysis time was 9.7 ± 3.2 min. AI analysis plus
quality assurance analysis and report generation was 23.7 ± 6.4 min
(Table 1).
Non-negligible plaque (>3 mm3) was detected by AI in the following
distributions: 170/232 (73.2%) in the RCA, 154/228 (67.5%) in the LM,
196/232 (84.5%) in the LAD, and 150/232 (64.7%) in the LCx. Fig. 1 is a
box plot illustration reflecting reader performance for quantifying
21
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Fig. 3. An example of coronary vessels with plaque volumes appropriate for each quintile vessels were subjectively categorized into groups 0–4 based on whether
there was no plaque present (0), minimal plaque present (1), mild amounts of plaque present (2), moderate amounts of plaque present (3) or severe volumes of plaque
present (4). High risk features are present in the final panel. LA-NCP is circled in red, evidence of positive remodeling is circled in blue. (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of this article.)
Table 2
Correlation and agreement trends between L3 readers and AI.

Table 1
Study Cohort demographics with AI analytic times.

Plaque
volume

% NCP vs. % CP

HRP

Reader

Spearman
correlation
coefficient

Spearman
correlation
coefficient

Weighted
kappa
coefficient

Spearman
correlation
coefficient

Weighted
kappa
coefficient

1
2
3

0.70262
0.68224
0.73835

0.37660
0.50706
0.60281

0.232
0.337
0.239

0.3620
0.3529
0.4421

0.224
0.261
0.166

Demographics and AI analysis data (N = 232)
Variable
Age ± SD
Female sex, mean (%)
Body mass index (BMI) ± SD
Hypertension, n (%)
Hyperlipidemia, n (%)
Diabetes mellitus, n (%)
Smoking, n (%)
Family history of coronary artery disease, n (%)
Statin therapy, n (%)
Antiplatelet therapy, n (%)
Beta-Blocker therapy, n (%)
Coronary artery calcium score, mean ± SDa

N (%)
60 ± 12 years
86 (37)
27.5 ± 6 kg/m2
142 (61)
161 (69)
67 (29)
88 (38)
116 (35)
159 (68)
84 (36)
58 (25)
150 ± 495 (Range 0–3607)

3.2. Interobserver variability and correlation with AI
Fig. 2 shows the 5 by 5 tables comparing reader assigned quintiles for
% NCP and % CP on a per-vessel territory basis with AI reference ranges.
Spearman coefficients for readers 1, 2, and 3 compared to AI were
0.37660, 0.50706, and 0.60281, respectively. The intra-class correlation
coefficient for a single score across readers was 0.68, higher than the
Spearman coefficient achieved by any individual reader to AI. The
weighted kappa coefficient measuring agreement between AI and
readers 1, 2, and 3 for quantifying % NCP vs. % CP was 0.232, 0.337, and
0.239, respectively. The Spearman coefficient demonstrating correlation
among readers 1, 2, and 3 for quantifying HRP was 0.362, 0.3529, and
0.4421, respectively. Agreement between AI and Readers 1, 2, and 3 for
quantifying HRP was poor with weighted kappa coefficients of 0.224,
0.261, and 0.166, respectively (Figs. 4-5). A matrix comparing HRP
detected by AI versus L3 readers is included in Fig. A2 of Appendix A.

AI analysis data
AI analysis series available, mean ± SD minutes
AI analysis time, mean ± SD minutes
AI analysis + QA analysis and report generation, mean ± SD
minutes

3.6 ± 1.6 (Range
1–10)
9.7 ± 3.2
23.7 ± 6.4

a
Coronary artery calcium score by the Agatston method was available for 147
of the 232 (63%) of patients as one of the sites does not routinely perform noncontrast calcium scoring prior to CCTA.

plaque on a per-vessel territory basis compared to those AI reference
measurements. The Spearman coefficients for readers 1, 2, and 3
compared to AI were 0.70262, 0.68224, and 0.73835, respectively
(Table 2). The intra-class correlation of a single score across readers was
0.77921 with a high intra-class correlation coefficient of 0.91370 for
mean scores.

4. Discussion
This study evaluates the interobserver variation for total plaque and
plaque component quantification among expert readers using reference
measurements from an FDA approved AI validated CCTA analysis
22
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Fig. 4. Example of L3 interobserver variability determining % NCP and % CP
63 year old man with stable chest pain. CCTA with discordant plaque composition was reported by readers. Curved multiplanar reformatted images (CPR) (2 left
images) depict a moderate volume of mixed density atherosclerotic plaque. Level 3 readers' estimates of the % non-calcified plaque included 10–40%, 40–60%, and
60–90%. AI-QCT images and analysis (3rd and 4th images from left, the yellow line is outer wall boundary, purple line lumen wall boundary; the color plaque
overlay: blue is calcified plaque, yellow noncalcified plaque, red low density noncalcified plaque) revealed that the percent noncalcified plaque was 58%. (For
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Fig. 5. Example of discordance between AI and L3 readers for identifying HRP
53 year old man with chest pain. This example illustrates a circumstance in which L3 readers and AI disagreed regarding the presence of HRP features (defined as LANCP and PR). Panel A shows a frontal view of a vessel that L3 readers identified as having HRP features. Reader perception of LA-NCP is circled in red. PR is circled in
blue. Panels B and D show sagittal views of that same vessel with color overlay representing signs of PR identified by AI. Panels C and E show transverse views of the
same vessel with AI analysis showing HU >30 (yellow), and consequently no LA-NCP. (For interpretation of the references to color in this figure legend, the reader is
referred to the web version of this article.)
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software and showed that expert readers perform moderately well
quantifying plaque volume at the vessel territory level with moderate to
high consistency among readers, but demonstrate high levels of inter
observer variability as well as discordance with AI when quantifying
plaque composition including %NCP, %CP and presence of HRP.
Our data reflect that there was high consistently among expert
readers but only moderate range performance quantifying total plaque
by vessel territory compared to AI-QCT. Our findings are consistent with
studies by Hoffmann et al. and Pearsons et al., both of which assessed
interobserver variation among expert readers quantifying total plaque
severity and found high interobserver consistency.8,19 However, our
findings diverge when assessing reader performance. While Hoffmann
et al. and Pearsons et al. had used consensus reads as a reference stan
dard and concluded that reader performance was strong, this study
notably uses AI-QCT as a reference, and in doing so, brings the short
comings of human reads into relief. Namely, while expert readers share a
high level of skill that may result in similar outcomes among other
expert readers, they nonetheless remain equally limited by the capa
bilities of human perception. By contrast, AI algorithms can evaluate
images at the level of each individual voxel providing an accuracy that
surpasses human capabilities.20
The extent of human limitation is magnified when evaluating expert
performance quantifying plaque components. In the literature, as in our
findings, interobserver variability increases and reader performance
declines. In Hoffmann et al., not only does the kappa coefficient for
quantifying %NCP v. %CP drop from high to moderate, but intraobserver variability also increases with a correlation of 0.68 between
reads (down from 0.90 for quantifying plaque).19
While our study compared expert readers among one another, their
calculations were also gauged against an FDA validated AI guided
software that has shown non-inferiority to invasive coronary angiog
raphy measurements for stenosis, plaque quantification and character
ization12,16 providing a non-biased comparison for reader performance.
Compared to AI-QCT performance, expert readers showed a weak to
moderately positive trend for quantifying %NCP vs. %CP with only fair
correlation with AI. Consistently, there was only slight to fair correlation
with AI-QCT when identifying HRP. The significance of these findings
lies in the established prognostic benefit of plaque characteristics and a
growing need for both quantifying high risk plaque features and tracking
their progression. For instance, the CREDENCE trial showed that ste
nosis and plaque features together provide a non-invasive approach for
predicting downstream ischemia that outperformed either stenosis alone
or myocardial perfusion imaging.3 Similarly, sub-studies of the SCOTHEART trial show that specific atherosclerotic plaque characteristics
(APCs) confer increased risk of myocardial events at five year follow up6
while the PARADIGM trial showed that baseline plaque volumes and the
presence of HRP influence the rate of plaque progression over a two year
period.21–23 These findings collectively emphasize the importance of
accurately identifying, quantifying and tracking plaque features. Our
study adds to this conversation by showing that not only are there
limitations on expert reader performance quantifying plaque and iden
tifying plaque features, but importantly that these limitations are miti
gated by using AI-QCT.
This is the first study to reflect expert interobserver performance for
categorizing plaque characteristics against a validated quantitative
reference. Given that new prognostic data support the quantification
and tracking of APCs including HRP, our data suggest that AI may have a
practical place in screening and monitoring plaque progression in
appropriate patients, as high variability and difficulty accurately cate
gorizing plaque components exists among expert readers. While the AI
program has been validated against expert readers,12 and quantitative
coronary angiography,13 studies are currently underway evaluating AI
performance against IVUS,24 optical coherence tomography, and near
field infrared spectroscopy to establish all-around performance against
the current gold standards.
This study has limitations. The present study was a post-hoc analysis

of the CLARIFY trial and, while it is unexpected that significant bias
would be introduced in a retrospective evaluation leveraging blinded
core laboratory readers, it nevertheless emphasizes the absence of a
prospective clinical trial that could be performed in the future. Addi
tionally, in this study, established HU thresholds for plaque character
ization were utilized without adjustment in the absence of a
standardized methodology for high luminal contrast enhancement. Ul
timately, AI was not performed on CCTAs of poor image quality deemed
uninterpretable by expert readers, further emphasizing limitations by
human readers versus AI. Finally, while the prognostic significance of
atherosclerotic plaque quantified by AI is still unknown, AI's high per
formance and the expanding knowledge surrounding the prognostic
value of adverse plaque substantiate that further investigation is
warranted.
5. Conclusion
Expert readers can quantify coronary plaque volume moderately
well with high interobserver consistency. However, quantifying specific
high risk coronary plaque components remains a challenge as high
variability remains among readers with high discordance compared to
AI-QCT.
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